“Reduction in Pruritus Across Indications in Phase 3 Trials of Topical Roflumilast in Patients As Young As 2 Years”. SKIN The Journal of Cutaneous Medicine 10, no. 2 (March 10, 2026): s766. Accessed April 30, 2026. https://skin.dermsquared.com/skin/article/view/4064.